Vaccine
Vaccine is a subscription (hybrid open access) journal published by Elsevier BV in the United Kingdom. OpenAlex counts 33,227 works from it, cited 1,231,437 times; its h-index is 284. Its two-year mean citedness, which is computed the way the impact factor is, is 3.97: a paper it published in the two years before was cited about 3.97 times last year. It published 1,275 papers in 2025, up 21% from 1,051 in 2024. Publishing a paper open access in it costs about US$3,620.
- Publisher
- Elsevier BV
- Citations per paper
- 3.97 two-year mean, OpenAlex
- h-index
- 284 i10-index 22,331
- Access
- Subscription · hybrid open access
- APC
- US$3,620 to publish open access
- ISSN
- 0264-410X, 1873-2518
- Country
- United Kingdom
- Works published
- 33,227 cited 1,231,437 times
- Papers in 2025
- 1,275
- Website
- Journal home ↗
Vaccine year by year
Papers it published each year, and the citations all its papers received that year.
| Year | Papers published | Citations received |
|---|---|---|
| 2026 so far | 979 | 54,561 |
| 2025 | 1,275 | 66,324 |
| 2024 | 1,051 | 70,181 |
| 2023 | 970 | 75,351 |
| 2022 | 1,037 | 75,362 |
| 2021 | 1,118 | 78,559 |
| 2020 | 1,057 | 66,626 |
| 2019 | 1,173 | 59,781 |
What Vaccine publishes
Its most frequent research topics, by OpenAlex's topic classification.
- Vaccine Coverage and HesitancyHealth · 7,780 papers
- Bacterial Infections and VaccinesMicrobiology · 6,007 papers
- Immunotherapy and Immune ResponsesImmunology · 5,057 papers
- Influenza Virus Research StudiesEpidemiology · 3,933 papers
- Virology and Viral DiseasesEpidemiology · 3,495 papers
Questions about Vaccine
What is the impact factor of Vaccine?
Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 3.97 for Vaccine: on average, each paper it published in the two years before was cited about 3.97 times in a year.
What is the h-index of Vaccine?
284, by OpenAlex's count: 284 of its papers have each been cited at least 284 times. Its i10-index is 22,331.
Is Vaccine open access?
Not fully. Vaccine is a subscription journal; a paper is free to read when its authors paid for open access or posted a copy in a repository.
What is the publication fee (APC) of Vaccine?
About US$3,620, which is the fee to publish a paper open access as listed by OpenAlex. Fees change and waivers exist, so check the journal's own page before you submit.
What is the ISSN of Vaccine?
Its linking ISSN is 0264-410X; all its ISSNs: 0264-410X, 1873-2518.
Who publishes Vaccine?
Elsevier BV, based in the United Kingdom.
How many papers does Vaccine publish a year?
1,275 in 2025, by OpenAlex's count of what it published that year.
What does Vaccine publish?
Its most frequent research topics are Vaccine Coverage and Hesitancy, Bacterial Infections and Vaccines, Immunotherapy and Immune Responses, in the field of Immunology and Microbiology.
Is Vaccine a predatory journal?
Nothing in the scholarly indexes suggests so. Vaccine is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 33,227 works cited 1,231,437 times. For a journal you do not know, check the red flags with our predatory journal checker.
Is Vaccine indexed in Scopus or Web of Science?
Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (0264-410X): both are free to search. Our guide on checking journal indexing shows each step.
Journals like Vaccine
Other Immunology and Microbiology journals with a similar impact.
Every Immunology and Microbiology journal, ranked · The journal directory
Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).